艾昆緯 IQV 深 滬
已收盤 02-06 16:00:00 美东时间
187.49
+6.530
+3.61%
華盛通- 最 高190.09
- 今 開183.12
- 成交量 344.30万股
- 最 低 182.77
- 昨 收 180.96
- 總市值 319.30亿
- 52周最高 247.045
- 市盈率 靜 23.91
- 換手率 2.02%
- 52周最低 134.645
- 委 比 -17.65%
- 總股本 1.70亿
- 歷史最高 285.61
- 量 比 1.15
- 振 幅 4.05%
- 歷史最低 81.79
- 每 手 1
- 風險率 29.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多财报速睇 | 艾昆纬 2025财年Q4营收43.64亿美元，同比增长10.3%；归母净利润5.14亿美元，同比增长17.6%
华盛资讯2月7日讯，艾昆纬公布2025财年Q4业绩，公司Q4营收43.64亿美元，同比增长10.3%，归母净利润5.14亿美元，同比增长17.6%。
今天 04:51
Barclays Maintains Equal-Weight on IQVIA Hldgs, Lowers Price Target to $210
Barclays analyst Luke Sergott maintains IQVIA Hldgs (NYSE:IQV) with a Equal-Weight and lowers the price target from $230 to $210.
02-06 23:26
IQVIA Hldgs Q4 Earnings Report: What Investors Need to Know
The Q4 earnings report for IQVIA Hldgs (NYSE:IQV) was released on Thursday, Feb...
02-05 20:06
ANALYSIS-Novo Nordisk risks weight-loss price war as discount pressures deepen
ANALYSIS-Novo Nordisk risks weight-loss price war as discount pressures deepen Analysts, investors fear price war in obesity drug market Novo cut Wegovy prices under Trump pressure, to win cash-pay patients Shares sink more than 15% on 2026 warning CEO: short-term price pain for volume, sales gains
02-04 22:29
诺和诺德、礼来迈入新时代，减肥药市场销售潜力遇冷
华尔街长期以来预测全球减肥药市场未来十年规模将达 1500 亿美元，而如今这一预期的确定性大幅降低：诺和诺德与礼来的胰高血糖素样肽 - 1（GLP-1）类减...
02-02 20:54
ANALYSIS-Obesity market sales potential tightens as Novo and Lilly enter new era
ANALYSIS-Obesity market sales potential tightens as Novo and Lilly enter new era Analysts revise obesity drug market forecasts due to price erosion Some analysts remain optimistic about $150 billion market potential Price cuts may boost volumes despite market uncertainty, some analysts say By Maggie
02-02 19:00
DIARY-U.S. earnings week ahead
DIARY-U.S. earnings week ahead Jan 30 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 02-Feb-2026 BMO APTV Aptiv PLC Q4 2025 Aptiv PLC Earnings Release 02-Feb-2026 AMC DVA DaVita Inc Q4 2025 DaVita Inc Earnings R
01-31 01:00
UPDATE 1-Novo's Wegovy pill surpasses 26,000 prescriptions in second full week
UPDATE 1-Novo's Wegovy pill surpasses 26,000 prescriptions in second full week Adds background in paragraphs 3 and 6 Jan 30 (Reuters) - Novo Nordisk's NOVOb.CO Wegovy pill hit over 26,000 U.S. prescriptions in the second full week after its launch, IQVIA data shared by an analyst on Friday showed. I
01-30 20:55
